Contract Development and Manufacturing Organization (CDMO)

We have 10-year-long term customers in the US for commercial products and are supplying Key intermediates to European customers and polymer API to Japanese originators that cover 50% global market share. In this year, we’ll have 30% growth of CRAMS business with integration of fill-finished projects.

Strategic partner for your success

1. From R&D process development to process validation
2. From pre-IND scale to commercial
3. From chemical sourcing to CMC documentation
4. From drug substance to drug product

All GMP-compliant

As a contract development and manufacturing organization (CDMO), Formosa Laboratories (Formosa Labs) offers full-service for both general and high potency API (HPAPI) for all stages of drug development for both clinical trial material (CTM) and commercialized (NDA). Our GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan since 2000.

Process development and route optimization are core competencies of our business. The company has a dedicated staff of professional process chemists and engineers with significant experience and expertise in the development of robust cGMP chemical processes.

With the fully-integrated R&D and manufacturing capabilities from API to FDF, Formosa is able to provide one-stop-shop CDMO services delivering our client drug product with price competitiveness and continuous supply.